194
Views
1
CrossRef citations to date
0
Altmetric
Review Articles

Multi-strategic approaches for enhancing active transportation using self-emulsifying drug delivery system

& ORCID Icon
Pages 726-736 | Received 03 Mar 2022, Accepted 19 Apr 2022, Published online: 03 May 2022

References

  • Shen J, Bi J, Tian H, et al. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with akebia saponin D-phospholipid complex. Int J Nanomedicine. 2016;11:4919–4929.
  • Saoji SD, Dave VS, Dhore PW, et al. The role of phospholipid as a solubility- and permeability-enhancing excipient for the improved delivery of the bioactive phytoconstituents of bacopa monnieri. Eur J Pharm Sci. 2017;108:23–35.
  • Li P, Tan A, Prestidge CA, et al. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Int J Pharm. 2014;477(1–2):390–398.
  • Poudwal S, Misra A, Shende P. Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists. J Drug Target. 2021;29(8):834–847.
  • Shende P, Ture N, Gaud RS, et al. Lipid- and polymer-based plexes as therapeutic carriers for bioactive molecules. Int J Pharm. 2019;558:250–260.
  • Nie T, He Z, Zhu J, et al. One-Pot synthesis of PEGylated lipoplexes to facilitate mucosal permeation for oral insulin gene delivery. Adv Therap. 2020;3(3):2000016–2000021.
  • Pravin S, Rohan K, Gaud RS. Nanostructured cochleates: a multi-layered platform for cellular transportation of therapeutics. Drug Dev Ind Pharm. 2019;45(6):869–881.
  • Zhang L, Zhang M, Pang Y, et al. Self-emulsifying drug delivery system and the applications in herbal drugs. Drug Deliv. 2015;22(4):475–486.
  • Gonçalves A, Nikmaram N, Roohinejad S, et al. Production, properties, and applications of solid self-emulsifying delivery systems (S-SEDS) in the food and pharmaceutical industries. Colloids Surfaces A Physicochem Eng Asp. 2018;538:108–126.
  • Mahmood A, Bernkop-Schnürch A. SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2019;142:91–101.
  • Kohli K, Chopra S, Dhar D, et al. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today. 2010;15(21–22):958–965.
  • Nikolakakis I, Partheniadis I. Self-Emulsifying granules and pellets: composition and formation mechanisms for instant or controlled release. Pharmaceutics. 2017;9(4):27–50.
  • Kamal MM, Salawi A, Lam M, et al. Development and characterization of curcumin-loaded solid self-emulsifying drug delivery system (SEDDS) by spray drying using soluplus® as solid carrier. Powder Technol [Internet]. 2020;369:137–145.
  • Timur SS, Yöyen-Ermiş D, Esendağlı G, et al. Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer. Eur J Pharm Biopharm. 2019;136:138–146.
  • Čerpnjak K, Zvonar A, Gašperlin M, et al. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm. 2013;63(4):427–445.
  • Krstić M, Medarević Đ, Đuriš J, et al. Self-nanoemulsifying drug delivery systems (SNEDDS) and self-microemulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs. Lipid Nanocarriers Drug Target. 2018;473–508.
  • Pattewar S, Kasture S, Pande V, et al. Self micro-emulsifying drug delivery system: a lipid based drug delivery system. Int J Pharm Sci Res. 2016;7:443.
  • Rahman A, Harwansh R, Mirza MA, et al. Oral lipid based drug delivery system (LBDDS): formulation, characterization and application: a review. Curr Drug Deliv. 2011;8(4):330–345.
  • Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3–4):278–287.
  • Pouton CW. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and “self-microemulsifying” drug delivery systems. Eur J Pharm Sci. 2000;11:93–98.
  • Mahapatra AK, Murthy PN, Swadeep B, et al. Self-emulsifying drug delivery systems (SEDDS): an update from formulation development to therapeutic strategies. Int J PharmTech Res. 2014;6:546–568.
  • Avula P, Desavathu M, Lingamdinne SR. A state of the art review on self emulsifying drug delivery system. Int J Pharmarceutical Sci Res. 2020;11:4244–4260.
  • Khatri P, Shao J. Mechanism and structural factors of lipid and surfactant in the formation of self-emulsified nanoemulsion. J Pharm Sci. 2018;107(8):2198–2207.
  • Pehlivanov I. self-emulsifying drug delivery systems (SEDDS): excipient selection, formulation and characterization. J IMAB. 2020;26(3):3226–3233.
  • Acosta E, Diosady L, Rao AV, et al. Self-emulsifying delivery systems and lipid transport. In: Ahmad MU, editor. Lipids Nanotechnol. AOCS Press; 2012. p. 135–170.
  • Khalil RA, Zarari AHA. Theoretical estimation of the critical packing parameter of amphiphilic self-assembled aggregates. Appl Surf Sci. 2014;318:85–89.
  • Fatouros DG, Deen GR, Arleth L, et al. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm Res. 2007;24(10):1844–1853.
  • Fong C, Krodkiewska I. Novel surfactants. FL, USA: CRC Press; 2003.
  • Baghel P, Roy A, Verma S, et al. Amelioration of lipophilic compounds in regards to bioavailability as self-emulsifying drug delivery system (SEDDS). Futur J Pharm Sci. 2020;6:21.
  • Leonaviciute G, Bernkop-Schnürch A. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery. Expert Opin Drug Deliv. 2015;12(11):1703–1716.
  • Zafar H, Kiani MH, Raza F, et al. Design of enzyme decorated mucopermeating nanocarriers for eradication of H. pylori infection. J Nanoparticle Res. 2020;22(1):1–21.
  • Wang X, He L, Wei B, et al. Bromelain-immobilized and lactobionic acid-modified chitosan nanoparticles for enhanced drug penetration in tumor tissues. Int J Biol Macromol. 2018;115:129–142.
  • Wei B, He L, Wang X, et al. Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study. J Biomater Appl. 2017;32(2):206–218.
  • Shahzadi I, Dizdarević A, Efiana NA, et al. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): key to enhanced mucus permeation. J Colloid Interface Sci. 2018;531:253–260.
  • Leichner C, Menzel C, Laffleur F, et al. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying drug delivery system (SEDDS). Int J Pharm. 2017;530(1-2):346–353.
  • Efiana NA, Phan TNQ, Wicaksono AJ, et al. Mucus permeating self-emulsifying drug delivery systems (SEDDS): about the impact of mucolytic enzymes. Colloids Surf B Biointerfaces. 2018;161:228–235.
  • Prüfert F, Fischer F, Leichner C, et al. Development and in vitro evaluation of stearic acid phosphotyrosine amide as new excipient for zeta potential changing self-emulsifying drug delivery systems. Pharm Res. 2020;37(4):10–1007.
  • Salimi E, Le-Vinh B, Zahir-Jouzdani F, et al. Self-emulsifying drug delivery systems changing their zeta potential via a flip-flop mechanism. Int J Pharm. 2018;550(1–2):200–206.
  • Wolf JD, Kurpiers M, Götz RX, et al. Phosphorylated PEG-emulsifier: powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS). Eur J Pharm Biopharm. 2020;150:77–86.
  • Suchaoin W, Pereira de Sousa I, Netsomboon K, et al. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation. Int J Pharm. 2016;510(1):255–262.
  • Sharifi F, Nazir I, Asim MH, et al. Zeta potential changing self-emulsifying drug delivery systems utilizing a novel Janus-headed surfactant: a promising strategy for enhanced mucus permeation. J Mol Liq. 2019;291:111285.
  • Zaichik S, Steinbring C, Jelkmann M, et al. Zeta potential changing nanoemulsions: impact of PEG-corona on phosphate cleavage. Int J Pharm. 2020;581:119299.
  • Kurpiers M, Wolf JD, Steinbring C, et al. Zeta potential changing nanoemulsions based on phosphate moiety cleavage of a PEGylated surfactant. J Mol Liq. 2020;316:113868.
  • Zhang J, Li J, Ju Y, et al. Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system. Mol Pharm. 2015;12(2):504–513.
  • Shanmugam S, Baskaran R, Balakrishnan P, et al. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein. Eur J Pharm Biopharm. 2011;79(2):250–257.
  • Shehata EMM, Elnaggar YSR, Galal S, et al. Self-emulsifying phospholipid pre-concentrates (SEPPs) for improved oral delivery of the anti-cancer genistein: development, appraisal and ex-vivo intestinal permeation. Int J Pharm. 2016;511(2):745–756.
  • Bravo-Alfaro DA, Muñoz-Correa MOF, Santos-Luna D, et al. Encapsulation of an insulin-modified phosphatidylcholine complex in a self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin delivery. J Drug Deliv Sci Technol. 2020;57:101622.
  • Wu Z, Guo D, Deng L, et al. Preparation and evaluation of a self-emulsifying drug delivery system of etoposide-phospholipid complex. Drug Dev Ind Pharm. 2011;37(1):103–112.
  • Liu J, Werner U, Funke M, et al. SEDDS for intestinal absorption of insulin: Application of caco-2 and caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats. Int J Pharm. 2019;560:377–384.
  • Tong Y, Zhang Q, Shi W, et al. Mechanisms of oral absorption improvement for insoluble drugs by the combination of phospholipid complex and SNEDDS. Drug Deliv. 2019;26(1):1155–1166.
  • Zhang J, Wen X, Dai Y, et al. Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex. Int J Nanomedicine. 2019;14:7095–7106.
  • Kalamkar R, Wadher S. Formulation and pharmacokinetic evaluation of phosal based zaltoprofen solid self-nanoemulsifying drug delivery system. Pharm Nanotechnol. 2019;7(4):328–338.
  • Liao H, Gao Y, Lian C, et al. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems. Int J Nanomedicine. 2019;14:7291–7306.
  • Savage GP. Saponins. Amsterdam, The Netherlands: Elsevier; 2003.
  • Wang Y, Shen J, Yang X, et al. Mechanism of enhanced oral absorption of akebia saponin D by a self-nanoemulsifying drug delivery system loaded with phospholipid complex. Drug Dev Ind Pharm. 2019;45(1):124–129.
  • Athmouni K, Mkadmini Hammi K, El Feki A, et al. Development of catechin-phospholipid complex to enhance the bioavailability and modulatory potential against cadmium-induced oxidative stress in rats liver. Arch Physiol Biochem. 2020;126(1):82–88.
  • Tran T, Xi X, Rades T, et al. Formulation and characterization of self-nanoemulsifying drug delivery systems containing monoacyl phosphatidylcholine. Int J Pharm. 2016;502(1–2):151–160.
  • Huang J, Chen PX, Rogers MA, et al. Investigating the phospholipid effect on the bioaccessibility of rosmarinic acid-phospholipid complex through a dynamic gastrointestinal in vitro model. Pharmaceutics. 2019;11(4):156.
  • Tran T, Siqueira SDVS, Amenitsch H, et al. In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems. J Control Release. 2017;255:45–53.
  • Asfour MH, Kassem AA, Salama A, et al. Hydrophobic ion pair loaded self-emulsifying drug delivery system (SEDDS): a novel oral drug delivery approach of cromolyn sodium for management of bronchial asthma. Int J Pharm. 2020;585:119494.
  • Nazir I, Asim MH, Dizdarević A, et al. Self-emulsifying drug delivery systems: impact of stability of hydrophobic ion pairs on drug release. Int J Pharm. 2019;561:197–205.
  • Ristroph KD, Prud'homme RK. Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1(11):4207–4237.
  • Schaper K-J, Zhang H, Raevsky OA. RO pH-dependent partitioning of acidic and basic drugs into liposomes—a quantitative structure‐activity relationship analysis. Quant Struct Act Relat. 2001;20(1):46–54.
  • Jirwankar P, Shah D, Shao J. Protection of protein drugs by self-emulsified nanoemulsion against proteolysis. J Pharm Sci. 2020;109(8):2615–2621.
  • Menzel C, Holzeisen T, Laffleur F, et al. In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide. J Control Release. 2018;277:165–172.
  • Karamanidou T, Karidi K, Bourganis V, et al. Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur J Pharm Biopharm. 2015;97(Pt A):223–229.
  • Phan TNQ, Le-Vinh B, Efiana NA, et al. Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction? J Drug Target. 2019;27(9):1017–1024.
  • Friedl JD, Jörgensen AM, Le Vinh B, et al. Solidification of self-emulsifying drug delivery systems (SEDDS): impact on storage stability of a therapeutic protein. J Colloid Interface Sci. 2021;584:684–697.
  • Leonaviciute G, Adamovic NT, Lam HT, et al. Self-emulsifying drug delivery systems (SEDDS): proof-of-concept how to make them mucoadhesive. Eur J Pharm Biopharm. 2017;112:51–57.
  • Hauptstein S, Prüfert F, Bernkop-Schnürch A. Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery. Int J Pharm. 2015;487(1-2):25–31.
  • Ismail R, Phan TNQ, Laffleur F, et al. Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery. Eur J Pharm Biopharm. 2020;152:10–17.
  • Lam HT, Le-Vinh B, Phan TNQ, et al. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity? J Pharm Pharmacol. 2019;71(2):156–166.
  • Jalil A, Asim MH, Nazir I, et al. Self-emulsifying drug delivery systems containing hydrophobic ion pairs of polymyxin B and agaric acid: a decisive strategy for enhanced antimicrobial activity. J Mol Liq. 2020;311:113298.
  • Dizdarević A, Efiana NA, Phan TNQ, et al. Imine bond formation: a novel concept to incorporate peptide drugs in self-emulsifying drug delivery systems (SEDDS). Eur J Pharm Biopharm. 2019;142:92–100.
  • Elbahwy IA, Lupo N, Ibrahim HM, et al. Mucoadhesive self-emulsifying delivery systems for ocular administration of econazole. Int J Pharm. 2018;541(1–2):72–80.
  • Sakloetsakun D, Dünnhaupt S, Barthelmes J, et al. Combining two technologies: Multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. Int J Biol Macromol. 2013;61:363–372.
  • Bernkop-Schnurch A, Malkawi A, Jalil A, et al. Self-emulsifying drug delivery systems: hydrophobic drug polymer complexes provide a sustained release in vitro. Mol Pharm. 2020;17(10):3709–3719.
  • Saifullah S, Kanwal T, Ullah S, et al. Design and development of lipid modified chitosan containing muco-adhesive self-emulsifying drug delivery systems for cefixime oral delivery. Chem Phys Lipids. 2021;235:105052.
  • Efiana NA, Mahmood A, Lam HT, et al. Improved mucoadhesive properties of self-nanoemulsifying drug delivery systems (SNEDDS) by introducing acyl chitosan. Int J Pharm. 2017;519(1–2):206–212.
  • Kontogiannidou E, Meikopoulos T, Virgiliou C, et al. Towards the development of Self-Nano-Emulsifying drug delivery systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: in vitro assessment and cytocompatibility studies. J Drug Deliv Sci Technol. 2020;56:101524.
  • Baba SP, Bhatnagar A. Role of thiols in oxidative stress. Curr Opin Toxicol. 2018;7:133–139.
  • Hetényi G, Griesser J, Nardin I, et al. Combination of SEDDS and preactivated thiomer technology: Incorporation of a preactivated thiolated amphiphilic polymer into self-emulsifying delivery systems. Pharm Res. 2017;34(6):1171–1179.
  • Batool A, Arshad R, Razzaq S, et al. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer. Int J Biol Macromol. 2020;152:503–515.
  • Cardona MI, Nguyen Le NM, Zaichik S, et al. Development and in vitro characterization of an oral self-emulsifying delivery system (SEDDS) for rutin fatty ester with high mucus permeating properties. Int J Pharm. 2019;562:180–186.
  • Leonaviciute G, Zupančič O, Prüfert F, et al. Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases. Int J Pharm. 2016;508(1–2):102–108.
  • Hetényi G, Griesser J, Moser M, et al. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm. 2017;523(1):357–365.
  • Parmar N, Singla N, Amin S, et al. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surf B Biointerfaces. 2011;86(2):327–338.
  • Hsu CY, Wang PW, Alalaiwe A, et al. Use of lipid nanocarriers to improve oral delivery of vitamins. Nutrients. 2019;11(1):30–68.
  • Rahman MA, Hussain A, Hussain MS, et al. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm. 2013;39(1):1–19.
  • Thomas N, Holm R, Garmer M, et al. Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. AAPS J. 2013;15(1):219–227.
  • Kollipara S, Gandhi RK. Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations. Acta Pharm Sin B. 2014;4(5):333–349.
  • Chudasama A, Patel V, Nivsarkar M, et al. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations. Drug Deliv. 2015;22(4):531–540.
  • Benito-Gallo P, Franceschetto A, Wong JCM, et al. Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis. Eur J Pharm Biopharm. 2015;93:353–362.
  • Shahba AAW, Mohsin K, Alanazi FK. Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in-vitro assessment. AAPS PharmSciTech [Internet]. 2012;13(3):967–977.
  • Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329(1–2):166–172.
  • Bu P, Ji Y, Narayanan S, et al. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using caco-2 cell model: polysorbate 80 as the surfactant. Eur J Pharm Sci. 2017;99:350–360.
  • Rohrer J, Zupančič O, Hetényi G, et al. Design and evaluation of SEDDS exhibiting high emulsifying properties. J Drug Deliv Sci Technol. 2018;44:366–372.
  • Zahir-Jouzdani F, Lupo N, Hermann M, et al. Glyceryl ester surfactants: Promising excipients to enhance the cell permeating properties of SEDDS. Eur J Pharm Biopharm. 2018;129:154–161.
  • Fortuna A, Alves G, Falcão A. The importance of permeability screening in drug discovery process: PAMPA, caco-2 and rat everted gut assays. Curr Top Pharmacol. 2007;11:63–86.
  • Luo Z, Liu Y, Zhao B, et al. Ex vivo and in situ approaches used to study intestinal absorption. J Pharmacol Toxicol Methods. 2013;68(2):208–216.
  • Sun H, Chow ECY, Liu S, et al. The caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol. 2008;4(4):395–411.
  • Lee JB, Zgair A, Taha DA, et al. Quantitative analysis of lab-to-lab variability in caco-2 permeability assays. Eur J Pharm Biopharm. 2017;114:38–42.
  • Arshad R, Tabish TA, Kiani MH, et al. A hyaluronic acid functionalized self-nano-emulsifying drug delivery system (snedds) for enhancement in ciprofloxacin targeted delivery against intracellular infection. Nanomaterials. 2021;11(5):1086.
  • Bremmell KE, Briskey D, Meola TR, et al. A self-emulsifying omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults. Eur J Nutr. 2020;59(6):2729–2737.
  • Knaub K, Sartorius T, Dharsono T, et al. A novel Self-Emulsifying drug delivery system (SEDDS) based on VESIsorb® formulation technology improving the oral bioavailability of cannabidiol in healthy subjects Katharina. Molecules. 2019;24(16):2913–2967.
  • Liu ZX, Artnuin C. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. Altern Ther Health Med. 2009;15(2):42.
  • Koehl NJ, Henze LJ, Kuentz M, et al. Supersaturated lipid-based formulations to enhance the oral bioavailability of venetoclax. Pharmaceutics. 2020;12(6):520–564.
  • Zaghloul A, Lila A, Abd-Allah F, et al. Probucol self-emulsified drug delivery system: stability testing and bioavailability assessment in human volunteers. Curr Drug Deliv. 2019;16(4):325–330.
  • Ayoub R, Page ST, Swerdloff RS, et al. Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive. Andrology. 2017;5(2):278–285.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.